| scholarly article | Q13442814 |
| P2093 | author name string | Schuchert A | |
| Hartung W | |||
| Seidl K | |||
| Tebbenjohanns J | |||
| P2860 | cites work | Malignant vasovagal syncope: a randomised trial of metoprolol and clonidine | Q24563053 |
| Value of sublingual isosorbide dinitrate before isoproterenol tilt test for diagnosis of neurally mediated syncope | Q33144637 | ||
| Effects of paroxetine hydrochloride, a selective serotonin reuptake inhibitor, on refractory vasovagal syncope: a randomized, double-blind, placebo-controlled study. | Q33144644 | ||
| Use of an extended monitoring strategy in patients with problematic syncope. Reveal Investigators | Q33175934 | ||
| Separating the primary autonomic failure syndromes, multiple system atrophy, and pure autonomic failure from Parkinson's disease. | Q33689741 | ||
| The syndrome of right bundle branch block ST segment elevation in V1 to V3 and sudden death--the Brugada syndrome | Q33935865 | ||
| Standards for analysis of ventricular late potentials using high resolution or signal-averaged electrocardiography. A statement by a Task Force Committee between the European Society of Cardiology, the American Heart Association and the American Col | Q37775418 | ||
| Value of the H-Q interval in patients with bundle branch block and the role of prophylactic permanent pacing | Q39561748 | ||
| Clinical utility of transthoracic two-dimensional and Doppler echocardiography | Q40658324 | ||
| Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators | Q44086151 | ||
| Usefulness of an aura for classification of a first generalized seizure | Q48921176 | ||
| Dynamics of circulatory adjustments to head-up tilt and tilt-back in healthy and sympathetically denervated subjects. | Q52240983 | ||
| The long QT syndrome | Q61850489 | ||
| Subclavian steal syndrome: existence, clinical features, diagnosis and management | Q71512393 | ||
| Screening for sinus node dysfunction by analysis of short-term sinus cycle variations on the surface electrocardiogram | Q71877833 | ||
| Risk stratification of patients with syncope | Q73205799 | ||
| A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators | Q73280436 | ||
| Coarctation of the left pulmonary artery: effects on the pulmonary vasculature of infants | Q73623182 | ||
| Vasoconstrictor reserve in neurally mediated syncope | Q73818193 | ||
| [Arrhythmogenic right ventricular cardiomyopathy. Etiology, diagnosis and therapy] | Q74569448 | ||
| Driving and heart disease | Q77309324 | ||
| Long-term outcome of patients with syncope associated with coronary artery disease and a nondiagnostic electrophysiologic evaluation | Q33144699 | ||
| Comparing two different protocols for tilt table testing: sublingual glyceryl trinitrate versus isoprenaline infusion | Q33144733 | ||
| Clinical significance of syncope in the electrophysiologic study versus electrocardiographic monitoring (ESVEM) trial. The ESVEM Investigators | Q33144677 | ||
| The ajmaline challenge in Brugada syndrome: diagnostic impact, safety, and recommended protocol | Q28178857 | ||
| Reproducibility of head-up tilt testing potentiated with sublingual nitroglycerin in patients with unexplained syncope | Q28373169 | ||
| "Brugada" syndrome: clinical data and suggested pathophysiological mechanism | Q31913453 | ||
| Neurally mediated syncope: pathophysiology and implications for treatment | Q33144496 | ||
| Increased orthostatic tolerance following moderate exercise training in patients with unexplained syncope | Q33144514 | ||
| Outcome of patients with nonischemic dilated cardiomyopathy and unexplained syncope treated with an implantable defibrillator | Q33144776 | ||
| Usefulness of a tilt training program for the prevention of refractory neurocardiogenic syncope in adolescents: A controlled study | Q33145054 | ||
| Putting it together: a new treatment algorithm for vasovagal syncope and related disorders | Q33145120 | ||
| Methodology of head-up tilt testing potentiated with sublingual nitroglycerin in unexplained syncope | Q33145406 | ||
| Comparison of diagnostic accuracy of sublingual nitroglycerin test and low-dose isoproterenol test in patients with unexplained syncope | Q33145448 | ||
| Syncope and seizures of psychogenic origin: identification with head-upright tilt table testing | Q33145733 | ||
| Complications of carotid sinus massage--a prospective series of older patients | Q33145957 | ||
| New classification of haemodynamics of vasovagal syncope: beyond the VASIS classification. Analysis of the pre-syncopal phase of the tilt test without and with nitroglycerin challenge. Vasovagal Syncope International Study | Q33146181 | ||
| Head-up tilt testing potentiated with oral nitroglycerin: a randomized trial of the contribution of a drug-free phase and a nitroglycerin phase in the diagnosis of neurally mediated syncope | Q33146182 | ||
| Diagnostic assessment of recurrent unexplained syncope with a new subcutaneously implantable loop recorder. Reveal-Investigators | Q33146189 | ||
| Psychological treatment of malignant vasovagal syncope due to bloodphobia | Q33146198 | ||
| Diagnostic value of history in patients with syncope with or without heart disease | Q33146450 | ||
| Guidelines on management (diagnosis and treatment) of syncope. | Q33146619 | ||
| Mechanism of syncope in patients with bundle branch block and negative electrophysiological test | Q33146969 | ||
| Epidemiologic study of migraine symptoms in young women | Q33147026 | ||
| Predicting the outcome of patients with unexplained syncope undergoing prolonged monitoring | Q33147459 | ||
| A randomized and controlled pilot trial of beta-blockers for the treatment of recurrent syncope in patients with a positive or negative response to head-up tilt test | Q33147763 | ||
| Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. | Q33147854 | ||
| Management of vasovagal syncope: controlling or aborting faints by leg crossing and muscle tensing | Q33148139 | ||
| Isometric arm counter-pressure maneuvers to abort impending vasovagal syncope | Q33148394 | ||
| Pacemaker therapy for prevention of syncope in patients with recurrent severe vasovagal syncope: Second Vasovagal Pacemaker Study (VPS II): a randomized trial. | Q33148932 | ||
| Evaluation and management of the patient with syncope | Q33150067 | ||
| Syncope in young adults: evidence for a combined medical and psychiatric approach | Q33151251 | ||
| Exertional syncope caused by left main coronary artery spasm | Q33151808 | ||
| Guidelines on management (diagnosis and treatment) of syncope-update 2004. Executive Summary | Q33152058 | ||
| Long-term outcome of paced and nonpaced patients with severe carotid sinus syndrome | Q33152190 | ||
| The vasovagal response | Q33153718 | ||
| Diagnostic Value of Carotid Sinus Hypersensitivity | Q33154373 | ||
| Evaluation of syncope by upright tilt testing with isoproterenol. A nonspecific test | Q33154912 | ||
| Neurally mediated syncope detected by carotid sinus massage and head-up tilt test in sick sinus syndrome | Q33157199 | ||
| Impairment of physical and psychosocial function in recurrent syncope | Q33157368 | ||
| Carotid sinus massage, eyeball compression, and head-up tilt test in patients with syncope of uncertain origin and in healthy control subjects | Q33157578 | ||
| Methodology of head-up tilt testing in patients with unexplained syncope | Q33157984 | ||
| Psychiatric syncope: a new look at an old disease. | Q33162229 | ||
| The duration of Holter monitoring in patients with syncope. Is 24 hours enough? | Q33162245 | ||
| Incremental diagnostic yield of loop electrocardiographic recorders in unexplained syncope | Q33162830 | ||
| Isoproterenol induction of vasodepressor-type reaction in vasodepressor-prone persons | Q33168931 | ||
| Role of invasive electrophysiologic testing in patients with symptomatic bundle branch block | Q33169960 | ||
| A novel psychophysiological treatment for vasovagal syncope | Q33175339 | ||
| Effects of chronic vasodilator therapy to enhance susceptibility to vasovagal syncope during upright tilt testing | Q33175399 | ||
| Adenosine-induced atrioventricular block in patients with unexplained syncope: the diagnostic value of ATP testing | Q33175445 | ||
| Comparison of tilt angles and provocative agents (edrophonium and isoproterenol) to improve head-upright tilt-table testing | Q33175499 | ||
| Tilt training: a new treatment for recurrent neurocardiogenic syncope and severe orthostatic intolerance | Q33175506 | ||
| Oral fluid therapy. A promising treatment for vasodepressor syncope | Q33175527 | ||
| Midodrine: a role in the management of neurocardiogenic syncope. | Q33175537 | ||
| Shortened head-up tilt testing potentiated with sublingual nitroglycerin in patients with unexplained syncope. | Q33175575 | ||
| Head-up tilt testing potentiated with low-dose sublingual isosorbide dinitrate: a simplified time-saving approach for the evaluation of unexplained syncope. | Q33175576 | ||
| Echocardiography in the diagnostic evaluation of syncope | Q33175600 | ||
| Final results from a pilot study with an implantable loop recorder to determine the etiology of syncope in patients with negative noninvasive and invasive testing | Q33175701 | ||
| Early effects of oral salt on plasma volume, orthostatic tolerance, and baroreceptor sensitivity in patients with syncope | Q33175831 | ||
| Usefulness of pindolol in neurocardiogenic syncope | Q33175868 | ||
| The natural course of untreated sick sinus syndrome and identification of the variables predictive of unfavorable outcome | Q33175883 | ||
| Cardioinhibitory reflex provoked by stimulation of carotid sinus in normal subjects and those with cardiovascular disease | Q33170287 | ||
| Electrophysiologic testing in bundle branch block and unexplained syncope | Q33172472 | ||
| Patients with syncope admitted to medical intensive care units | Q33173137 | ||
| Randomized double-blind, placebo-controlled trial of oral atenolol in patients with unexplained syncope and positive upright tilt table test results | Q33173519 | ||
| Psychiatric illnesses in patients with syncope | Q33173521 | ||
| Pathophysiology of carotid sinus hypersensitivity in elderly patients | Q33173581 | ||
| Efficacy of pindolol for treatment of vasovagal syncope | Q33173596 | ||
| Diagnostic value of programmed ventricular stimulation in patients with bifascicular block: A prospective study of patients with and without syncope | Q33173619 | ||
| Value of head-up tilt testing potentiated with sublingual nitroglycerin to assess the origin of unexplained syncope | Q33173635 | ||
| The value of the clinical history in the differentiation of syncope due to ventricular tachycardia, atrioventricular block, and neurocardiogenic syncope | Q33173742 | ||
| Diagnostic accuracy of a low-dose isoproterenol head-up tilt protocol | Q33173763 | ||
| Provocation of hypotension during head-up tilt testing in subjects with no history of syncope or presyncope | Q33173817 | ||
| Exercise-induced complete heart block in a patient with chronic bifascicular block | Q33173845 | ||
| Atrioventricular block progression in patients with bifascicular block assessed by repeated electrocardiography and a bradycardia-detecting pacemaker | Q33173986 | ||
| The value of tilt table testing with isoproterenol in determining therapy in adults with syncope and presyncope of unexplained origin | Q33174055 | ||
| Syncope: a videometric analysis of 56 episodes of transient cerebral hypoxia | Q33174069 | ||
| Neural control mechanisms and vasovagal syncope | Q33174315 | ||
| Nitroglycerin infusion during upright tilt: a new test for the diagnosis of vasovagal syncope | Q33174321 | ||
| Electrophysiologic study and ergonovine provocation of coronary spasm in unexplained syncope. | Q33174365 | ||
| Clinical characteristics of vasodepressor, cardioinhibitory, and mixed carotid sinus syndrome in the elderly | Q33174406 | ||
| Syncope in advanced heart failure: high risk of sudden death regardless of origin of syncope | Q33174446 | ||
| Usefulness of metoprolol for unexplained syncope and positive response to tilt testing in young persons | Q33174474 | ||
| New insights into the pathophysiology of carotid sinus syndrome | Q33174643 | ||
| Is syncope a risk factor for poor outcomes? Comparison of patients with and without syncope | Q33174680 | ||
| Prospective evaluation of infrahisal second-degree AV block induced by atrial pacing in the presence of chronic bundle branch block and syncope | Q33174761 | ||
| Tilt table testing for assessing syncope. American College of Cardiology | Q33174782 | ||
| Echocardiography in the evaluation of patients with syncope | Q33174807 | ||
| Personal and public safety issues related to arrhythmias that may affect consciousness: implications for regulation and physician recommendations. A medical/scientific statement from the American Heart Association and the North American Society of P | Q33174830 | ||
| Comparative study of the efficacy of metoprolol and verapamil in patients with syncope and positive head-up tilt test response. | Q33174837 | ||
| Effect of patient characteristics on the yield of prolonged baseline head-up tilt testing and the additional yield of drug provocation | Q33174968 | ||
| Vasodepressor syncope due to subclinical myocardial ischemia | Q33175035 | ||
| Assessment of a newly recognized association. Carotid sinus hypersensitivity and denervation of sternocleidomastoid muscles | Q33175218 | ||
| Diagnosing syncope. Part 2: Unexplained syncope. Clinical Efficacy Assessment Project of the American College of Physicians | Q33175246 | ||
| Can adenosine 5'-triphosphate be used to select treatment in severe vasovagal syndrome? | Q33175331 | ||
| P433 | issue | 9 | |
| P921 | main subject | syncope | Q180007 |
| P304 | page(s) | 592-612 | |
| P577 | publication date | 2005-09-01 | |
| P1433 | published in | Clinical Research in Cardiology | Q2665050 |
| P1476 | title | Commentary on the guidelines the diagnosis and the therapy of syncope--the European Society of Cardiology 2001 and the update 2004 | |
| P478 | volume | 94 |
| Q33157969 | A patient with syncope |
| Q33165099 | Cardiogenic syncope |
| Q33157034 | Diagnostics of patients with syncope of unknown origin: indications for hospital admission and for in- and out-hospital services? |
| Q37200618 | European National Society Cardiovascular Journals. Background, rationale and mission statement of the "Editors' Club" (Task Force of the European Society of Cardiology). |
| Q81715784 | European National Society Cardiovascular Journals: Background, rationale and mission statement of the 'Editors' Club' (Task Force of the European Society of Cardiology) |
| Q33799060 | European National Society Cardiovascular Journals: Background, rationale and mission statement of the 'Editors' Club' (Task Force of the European Society of Cardiology). |
| Q33156776 | Event-recorder |
| Q59383668 | Leitlinien zur Herzschrittmachertherapie |
| Q33168303 | Syncope in older patients : Who needs what and when? |
| Q33155899 | Syncope. A diagnostic challenge |
| Q33159994 | [Cardiac syncope : diagnosis and therapy]. |
Search more.